SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-23-161613
Filing Date
2023-06-06
Accepted
2023-06-06 16:12:01
Documents
15
Period of Report
2023-06-06
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d501696d8k.htm   iXBRL 8-K 28393
2 EX-99.1 d501696dex991.htm EX-99.1 9589
3 EX-99.2 d501696dex992.htm EX-99.2 29342
7 GRAPHIC g501696g0606111643648.jpg GRAPHIC 4101
  Complete submission text file 0001193125-23-161613.txt   204049

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA ions-20230606.xsd EX-101.SCH 2850
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE ions-20230606_lab.xml EX-101.LAB 17235
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ions-20230606_pre.xml EX-101.PRE 10812
9 EXTRACTED XBRL INSTANCE DOCUMENT d501696d8k_htm.xml XML 3267
Mailing Address 2855 GAZELLE COURT CARLSBAD CA 92010
Business Address 2855 GAZELLE COURT CARLSBAD CA 92010 7609319200
IONIS PHARMACEUTICALS INC (Filer) CIK: 0000874015 (see all company filings)

IRS No.: 330336973 | State of Incorp.: CA | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-19125 | Film No.: 23996186
SIC: 2834 Pharmaceutical Preparations